pI: 9.3008 |
Length (AA): 2055 |
MW (Da): 243213 |
Paralog Number:
1
Signal peptide: Y | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 21 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
796 | 998 | 1z40 (A) | 203 | 432 | 26.00 | 0 | 0.92 | 0.06 | 1.03 |
1103 | 1385 | 1c1g (A) | 2 | 281 | 16.00 | 0.00000027 | 0.04 | 0.27 | -0.13 |
221 | 441 | 4uv6 (A) | 144 | 397 | 28.00 | 0.0061 | 1 | 0.151043 | 1.08 |
505 | 608 | 1yn3 (A) | 157 | 254 | 15.00 | 0.004 | 0.24 | 0.203808 | -0.71 |
796 | 998 | 3zwz (A) | 203 | 432 | 28.00 | 0.0017 | 1 | 0.271283 | 0.69 |
796 | 998 | 4r1a (A) | 203 | 432 | 33.00 | 0.014 | 0.93 | 0.176283 | 0.77 |
898 | 1262 | 1f5n (A) | 194 | 583 | 15.00 | 0.89 | 0.02 | 0.177116 | 0.49 |
1020 | 1238 | 4gnk (E) | 936 | 1180 | 17.00 | 0.88 | 0.12 | 0.327069 | -1.02 |
1064 | 1314 | 4hse (A) | 246 | 528 | 29.00 | 0.22 | 0.04 | 0.150641 | 0.57 |
1103 | 1242 | 4wik (A) | 448 | 594 | 24.00 | 0.54 | 0.02 | 0.289627 | -0.73 |
1405 | 1695 | 3hjl (A) | 5 | 323 | 27.00 | 0.037 | 1 | 0.321106 | 0.22 |
1441 | 1512 | 4o9b (A) | 263 | 334 | 29.00 | 0.88 | 0.14 | 0.586536 | -2.76 |
1524 | 1754 | 4tql (A) | 10 | 238 | 37.00 | 0 | 1 | 0.570909 | -1.07 |
1595 | 1781 | 4uos (A) | 1 | 183 | 32.00 | 0.0000027 | 0.98 | 0.685498 | -2.35 |
1638 | 1695 | 1lq7 (A) | 2 | 66 | 55.00 | 0.047 | 0.77 | 0.671724 | -1.65 |
1654 | 1791 | 3hhm (B) | 430 | 575 | 24.00 | 0.44 | 0.52 | 0.424653 | -1.44 |
1667 | 1787 | 2dq3 (A) | 8 | 137 | 32.00 | 0.97 | 1 | 0.153381 | -0.23 |
1899 | 1981 | 2rji (A) | 1 | 84 | 48.00 | 0.000000000022 | 1 | 0.805889 | -2.24 |
509 | 608 | 1yn3 (A) | 161 | 254 | 16.00 | 0.16 | 0.29 | 0.232329 | -0.84 |
876 | 1095 | 4tql (A) | 9 | 231 | 10.00 | 0.046 | 0.02 | 0.239765 | -0.79 |
1020 | 1238 | 4gnk (E) | 936 | 1180 | 17.00 | 0.8 | 0.1 | 0.31527 | -0.88 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | sporozoite, Sporozoite, Male Gametocyte. | PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | early trophozoite, Ring, Female Gametocyte. | PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 24 hs, intra-erythrocytic - 40 hs, gametocyte, late trophozoite, Oocyst. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 48 hs. | Otto TD |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_126854)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G36520 | chaperone DnaJ-domain containing protein |
Babesia bovis | BBOV_I002740 | 200 kDa antigen p200 |
Brugia malayi | Bm1_05690 | Low-density lipoprotein receptor domain class A containing protein |
Brugia malayi | Bm1_14520 | Immunoglobulin I-set domain containing protein |
Brugia malayi | Bm1_32990 | Apical junction molecule protein 1 |
Brugia malayi | Bm1_17345 | Low-density lipoprotein receptor domain class A containing protein |
Candida albicans | CaO19.14055 | lysine/glutamic acid-rich protein |
Candida albicans | CaO19.6763 | lysine/glutamic acid-rich protein |
Caenorhabditis elegans | CELE_H39E23.3 | Protein H39E23.3 |
Caenorhabditis elegans | CELE_F49E2.5 | Protein F49E2.5, isoform E |
Caenorhabditis elegans | CELE_C25A11.4 | Protein AJM-1, isoform E |
Cryptosporidium parvum | cgd4_770 | Low complexity protein with large Glu repeat |
Dictyostelium discoideum | DDB_G0270864 | hypothetical protein |
Dictyostelium discoideum | DDB_G0285911 | LIM-type zinc finger-containing protein |
Drosophila melanogaster | Dmel_CG31551 | CG31551 gene product from transcript CG31551-RA |
Drosophila melanogaster | Dmel_CG2839 | CG2839 gene product from transcript CG2839-RA |
Entamoeba histolytica | EHI_059670 | Rab family GTPase |
Entamoeba histolytica | EHI_050660 | hypothetical protein, conserved |
Entamoeba histolytica | EHI_124620 | hypothetical protein |
Giardia lamblia | GL50803_24122 | Spindle pole protein, putative |
Homo sapiens | ENSG00000159450 | trichohyalin |
Homo sapiens | ENSG00000100285 | neurofilament, heavy polypeptide |
Leishmania braziliensis | LbrM.27.0260 | kinetoplast-associated protein-like protein |
Leishmania braziliensis | LbrM.28.2410 | glycoprotein 96-92, putative |
Leishmania braziliensis | LbrM.27.0250 | kinetoplast-associated protein-like protein |
Leishmania donovani | LdBPK_282370.1 | glycoprotein 96-92, putative |
Leishmania infantum | LinJ.28.2370 | glycoprotein 96-92, putative |
Leishmania infantum | LinJ.27.0250 | kinetoplast-associated protein-like protein |
Leishmania major | LmjF.27.0240 | kinetoplast-associated protein-like protein |
Loa Loa (eye worm) | LOAG_06076 | hypothetical protein |
Loa Loa (eye worm) | LOAG_01250 | immunoglobulin I-set domain-containing protein |
Loa Loa (eye worm) | LOAG_15228 | hypothetical protein |
Loa Loa (eye worm) | LOAG_06077 | hypothetical protein |
Loa Loa (eye worm) | LOAG_10697 | hypothetical protein |
Loa Loa (eye worm) | LOAG_05014 | hypothetical protein |
Loa Loa (eye worm) | LOAG_10695 | hypothetical protein |
Mus musculus | ENSMUSG00000052415 | trichohyalin |
Mus musculus | ENSMUSG00000020396 | neurofilament, heavy polypeptide |
Neospora caninum | NCLIV_015050 | Proteophosphoglycan ppg4, related |
Neospora caninum | NCLIV_007540 | hypothetical protein, conserved |
Neospora caninum | NCLIV_057110 | IQ calmodulin-binding motif domain-containing protein, putative |
Oryza sativa | 4339717 | Os05g0579900 |
Oryza sativa | 4326602 | Os01g0634300 |
Plasmodium berghei | PBANKA_0901300 | membrane associated erythrocyte binding-like protein |
Plasmodium falciparum | PF3D7_1147800 | membrane associated erythrocyte binding-like protein |
Plasmodium falciparum | PF3D7_0504700 | centrosomal protein CEP120, putative |
Plasmodium knowlesi | PKNH_0945700 | membrane associated erythrocyte binding-like protein, putative |
Plasmodium vivax | PVX_097685 | merozoite surface protein 3 |
Plasmodium vivax | PVX_097690 | merozoite surface protein 3 |
Plasmodium vivax | PVX_097710 | merozoite surface protein 3 |
Plasmodium vivax | PVX_092975 | merozoite adhesive erythrocytic binding protein |
Plasmodium vivax | PVX_097700 | merozoite surface protein 3 |
Plasmodium vivax | PVX_002510 | Nucleosomal binding protein 1, putative |
Plasmodium yoelii | PY05977 | erythrocyte binding protein |
Schmidtea mediterranea | mk4.000282.00 | |
Trypanosoma brucei gambiense | Tbg972.7.8700 | hypothetical protein, conserved |
Trypanosoma brucei gambiense | Tbg972.8.7560 | kinetoplast-associated protein, putative |
Trypanosoma brucei gambiense | Tbg972.4.5305 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.8.7260 | kinetoplast-associated protein, putative |
Trypanosoma brucei | Tb927.4.5120 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.7.7400 | Basal body protein |
Trypanosoma congolense | TcIL3000_7_6020 | hypothetical protein, conserved |
Trypanosoma congolense | TcIL3000_8_7490 | hypothetical protein, conserved |
Trypanosoma congolense | TcIL3000_8_7380 | kinetoplast-associated protein, putative |
Trypanosoma cruzi | TcCLB.510593.49 | kinetoplast DNA-associated protein, putative |
Trypanosoma cruzi | TcCLB.510609.60 | Basal body protein |
Trypanosoma cruzi | TcCLB.507969.10 | vesicular transport-associated repeat protein, putative |
Trypanosoma cruzi | TcCLB.506303.80 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.506811.160 | R27-2 protein, putative |
Trypanosoma cruzi | TcCLB.507895.124 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_309160 | IgA-specific metalloendopeptidase |
Toxoplasma gondii | TGME49_313900 | non-specific serine/threonine protein kinase |
Treponema pallidum | TP0769 | outer membrane protein (tmpB) |
Theileria parva | TP01_0576 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_413070 | trichohyalin, putative |
Trichomonas vaginalis | TVAG_295230 | hypothetical protein |
Trichomonas vaginalis | TVAG_168130 | axoneme-associated protein mst101, putative |
Trichomonas vaginalis | TVAG_459620 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_141490 | Moesin, putative |
Trichomonas vaginalis | TVAG_399600 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_028600 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_354150 | trichohyalin, putative |
Trichomonas vaginalis | TVAG_221970 | trichohyalin, putative |
Trichomonas vaginalis | TVAG_368240 | axoneme-associated protein mst101, putative |
Trichomonas vaginalis | TVAG_144410 | trichohyalin, putative |
Trichomonas vaginalis | TVAG_210560 | trichohyalin, putative |
Trichomonas vaginalis | TVAG_298320 | trichohyalin, putative |
Trichomonas vaginalis | TVAG_398490 | trichohyalin, putative |
Trichomonas vaginalis | TVAG_295240 | hypothetical protein |
Trichomonas vaginalis | TVAG_005450 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.4.5120 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.5120 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.5120 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.4.5120 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.8.7260 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.7260 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.7260 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.8.7260 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.7.7400 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.7400 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.7400 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.7.7400 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C25A11.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C25A11.4 | Caenorhabditis elegans | slow growth | wormbase |
CELE_F49E2.5 | Caenorhabditis elegans | larval lethal | wormbase |
TGME49_313900 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_309160 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_313900 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_309160 | Toxoplasma gondii | Probably non-essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.